Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high‐dose methylprednisolone, revisited

High‐dose methylprednisolone plus rituximab (R‐HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo‐immunotherapy and has proven its utility on the treatment of CLL/SLL complicated by auto‐immune cytopenias. We performed a retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Vagos Mata, Ana, Espada, Eduardo, Alves, Daniela, Polo, Blanca, Costa, Maria João, Lopes, Conceição, F. Lacerda, João, Raposo, João
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683540/
https://www.ncbi.nlm.nih.gov/pubmed/34783174
http://dx.doi.org/10.1002/cam4.4374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683540/
https://www.ncbi.nlm.nih.gov/pubmed/34783174
http://dx.doi.org/10.1002/cam4.4374

Ejemplares similares